/PRNewswire/ X-Therma Inc., a biotechnology company developing a breakthrough platform for regenerative medicine and organ preservation, has achieved GMP.
X-Therma s $22 4M Series B Sets Stage to Transform Regenerative Medicine and Organ Transplantation streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ X-Therma Inc., a biotechnology company developing a breakthrough platform for regenerative medicine and organ preservation, has completed an.
3 Factors Supporting the Increasing Demand For Biopreservation The healthcare industry is witnessing a significant evolution over the years with biopreservation being the need of the hour. Biopreservation techniques are well-known to maintain the functionality and integrity of regenerative medicines, that come.
RICHMOND, Calif. (BUSINESS WIRE) X-Therma Inc., a biotechnology company developing breakthrough technology for regenerative medicine and organ preservation - announced today that The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has granted its proprietary organ preser.